Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Handgrip strength and portal vein blood flow in people with liver cirrhosis

Official title: Effect of Handgrip Strength on Portal Vein Hemodynamics in Patients With Liver Cirrhosis

Run by Shanxi Provincial People's Hospital · NCT07116096 · Data updated 2026-11-12

This trial will test whether squeezing a handgrip changes portal vein and left gastric vein pressures and blood flow in adults with liver cirrhosis to see if muscle strength affects variceal hemodynamics.

More Liver Cirrhosis trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment120 (estimated)
SponsorShanxi Provincial People's Hospital
Government
Locations2 sites (Luoyang, Henan and 1 other locations)
StatusRecruiting
StartedAugust 17, 2025
Main results expectedAugust 15, 2027
Study endsAugust 15, 2027
Registry record updatedSeptember 15, 2026
Trial IDNCT07116096 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) with clinically diagnosed liver cirrhosis and endoscopically characterized esophagogastric varices who can perform a maximal handgrip and give informed consent are ideal candidates.

Probably not a fit

Patients with severe cardiac or pulmonary disease, uncontrolled infection, high MELD/Child-Pugh scores beyond inclusion limits, active uncontrollable bleeding, or other exclusion criteria are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will use a hand dynamometer to measure maximum handgrip strength and simultaneously record portal and left gastric vein pressures, flow velocity, and flow direction. Participants are divided into three assessment groups: direct portal pressure measurement during TIPS placement, Doppler ultrasound measurement, and endoscopic ultrasound measurement. Hemodynamic indices are recorded before and immediately after the handgrip maneuver to compare changes. The study targets correlations between a simple muscle-strength test and acute changes in portal-systemic blood flow that relate to gastroesophageal varices.

Why it matters

Potential benefit: If successful, this could provide a simple bedside maneuver to reveal changes in portal hemodynamics that help predict or manage variceal risk in cirrhosis patients.

How similar studies have gone: Handgrip strength has been linked to prognosis in cirrhosis, but using it to provoke and measure portal venous hemodynamic changes is a novel and largely untested approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged ≥18 years old
* Clinically diagnosed with liver cirrhosis
* Endoscopic observation to determine the presence of esophagogastric varices
* Only eligible for the portal vein pressure measurement group if there are no signs of variceal bleeding for at least 14 days
* Participant or guardian is capable of comprehending the study protocol, willing to participate, and able to provide written informed consent

Exclusion Criteria:

* Severe congestive heart failure, or severe untreated valvular heart disease
* Moderate to severe pulmonary hypertension
* Uncontrolled systemic infection
* Lesions (e.g., cysts) or tumors in the liver parenchyma that preclude TIPS creation
* Overt hepatic encephalopathy
* Unrelieved biliary obstruction
* Child-Pugh score \> 13
* MELD score \> 18
* INR \> 5
* Platelet count \< 20 ×109/mm3
* No gastrointestinal bleeding (suitable for the ultrasound examination group and the endoscopic ultrasonography group)
* Participants who had undergone hand or wrist surgery within the previous 3 months or were unable to hold the dynamometer with the testing hand were excluded from the study.

Where it's running

  • The First Affiliated Hospital of Henan University of Science and Technology
    Luoyang, Henan, China
    Recruiting
  • Shanxi Provincial People's Hospital
    Taiyuan, Shanxi, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Coil-assisted small-diameter stent shunt reduction for refractory HE after TIPS

    A coil-assisted, small-diameter covered-stent technique is being tested to see if it can safely and effectively reduce shunt flow and lessen recurrent hepatic encephalopathy in people with a prior TIPS.

    Recruiting Air Force Military Medical University, China · Xi'an, Shaanxi · NCT07799948

  • Austrian PBC Registry

    This registry follows adults with primary biliary cholangitis in Austrian centers to see how the disease develops over time and how biomarkers relate to complications and symptoms.

    Recruiting Medical University of Vienna · Klagenfurt, Carinthia and 10 other locations · NCT07598669

  • Blood clotting and portal vein changes during TIPS placement in cirrhosis

    This project will see how blood clotting in the body and in the portal vein changes in adults with cirrhosis who are having a TIPS placed.

    Recruiting Assistance Publique - Hôpitaux de Paris · Villejuif · NCT07439939

  • Early TIPS for patients with liver cirrhosis and ascites

    This study is testing if a procedure called TIPS can help people with liver cirrhosis and fluid buildup in their abdomen feel better compared to standard treatments like medications and draining the fluid.

    Recruiting University Hospital Freiburg · Freiburg im Breisgau · NCT06576934

  • Using Ga-PSMA PET/MRI to assess liver cirrhosis

    This study is testing a new imaging method to see if it can help doctors better understand liver function and damage in people with liver cirrhosis.

    Recruiting Massachusetts General Hospital · Charlestown, Massachusetts · NCT06265272

  • Registry for patients undergoing TIPS implantation for portal hypertension

    This study is collecting information from patients with serious portal hypertension who are getting a TIPS procedure to see how well it works and what complications might happen afterward.

    Recruiting University Hospital Freiburg · Freiburg im Breisgau · NCT05782556

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.